Top 10 Spatial Biology Companies of 2024
As research institutions worldwide expand their spatial efforts, providers of spatial technology consolidate, shaking up GEN’s rankings
Recent news about business developments
The top two private companies in spatial biology based on their total capital raised, Vizgen and Ultivue, merged in October into a single entity that aspires to be a powerhouse in the field by offering both single-cell spatial genomics and multiplex proteomic profiling technologies to customers engaged in foundational and clinical research.
The Vizgen-Ultivue merger reflects continuing consolidation in spatial biology, as does Bruker’s acquisition of NanoString Technologies by placing the winning $392.6 million bid for the company at a bankruptcy court auction earlier this year. Bio-Techne kicked off the current round of mergers and acquisitions last year by snapping up Swiss-based Lunaphore.
Top Private Companies |
1. Vizgen (merged with Ultivue)Total Capital Raised: “More than” $250 million Vizgen cemented its leadership spot among private spatial biology companies on October 9, when it announced a merger with Ultivue. Rob Carson, the merged Vizgen’s president and CEO (and previously Ultivue’s president and CEO), told GEN that the combined company—which carries the Vizgen name—will build upon its namesake predecessor’s expertise in single-cell spatial genomics and Ultivue’s leadership in multiplex proteomic profiling. The new Vizgen also aims to grow its presence in clinical laboratory settings while continuing to serve customers in research institutions and biopharmaceutical companies. “For spatial analysis to reach its full potential, it’s going to have to reach the point of having clinical utility,” Carson told GEN. |